Buscar
Mostrando ítems 11-20 de 27
New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview
(2020-05)
Non-infectious uveitis (NIU) is a group of disorders characterized by intraocular inflammation at different levels of the eye. NIU is a leading cause of irreversible blindness in working-age population in the developed ...
Impacto do uso de agentes ANTI-TNF á na funcionalidade de pacientes com Artrite Reumatoide, Espondilite Anquilosante e Artrite Psoriásica
(Universidade Federal de Minas GeraisUFMG, 2014-06-05)
Rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are chronic inflammatory diseases that affect a portion of the worlds population leading to direct physical limitation with impairment ...
Análise farmacoepidemiológica e farmacoeconômica do tratamento da espondilite anquilosante com os bloqueadores do fator de necrose tumoral (TNF)
(Universidade Federal de Minas GeraisUFMG, 2015-07-10)
Introduction. Ankylosing spondylitis (AS) is a chronic disease that primarily affects the spine and is characterized by inflammation and pain. In the Brazilian Health System (SUS) the disease-modifying antirheumatic drugs ...
Eventos adversos do tratamento medicamentoso de pacientes com doenças reumáticas autoimunes na infância: uma coorte retrospectiva em centro único
(Universidade Federal de São Paulo (UNIFESP), 2018-03-08)
Introduction: Autoimmune rheumatic diseases (AIRDs) are inflammatory diseases caused by changes in the immune system, and are manifested by joint involvement, as well as involvement of other organs and systems. Treatment ...
New pharmacological strategies for the treatment of non-infectious Uveitis. A Minireview
(Frontiers Media, 2020)
Non-infectious uveitis (NIU) is a group of disorders characterized by intraocular inflammation at different levels of the eye. NIU is a leading cause of irreversible blindness in working-age population in the developed ...
Terapias emergentes en artritis reumatoide
(Sociedad Médica de Santiago, 2005)
The use of biological agents such as etanercept, infliximab,
adalimumab and anakinra has been recently approved for the treatment of rheumatoid arthritis. All
are effective controlling signs and symptoms and inhibiting ...
Caracterização do perfil de segurança infeccioso dos anticorpos monoclonais imunossupressores
(Universidade Federal de São Paulo (UNIFESP), 2021)
The occurrence of infections is a widely known adverse event for immunosuppressive drugs, including monoclonal antibodies (mAB). However, immunosuppressive therapy is not the only risk factor for the development of infections. ...
Efetividade clínica dos medicamentos biológicos anti-TNF, biológicos não anti-TNF e sintético alvo-específico no tratamento da artrite reumatoide.
(Universidade Federal de Minas GeraisBrasilFARMACIA - FACULDADE DE FARMACIAPrograma de Pós-Graduação em Medicamentos e Assistencia FarmaceuticaUFMG, 2022-02-24)
Introduction: Rheumatoid Arthritis is a systemic, chronical inflammatory disease
associated to peripheral polyarthritis, which leads to deformity and destruction of
joints due to erosion of cartilage and bone. Treatment ...
Therapeutic monoclonal antibodies in ophthalmology
(Elsevier B.V., 2009-03-01)
Monoclonal antibodies (mAbs) can be used therapeutically by binding to molecular targets with high specificity. Therefore, they have excellent therapeutic applications in ophthalmology. This manuscript presents four aspects ...